Transforming growth factor β isoforms in human glomerulonephropathies

Nephrology

Volumn 4, Issue 5-6, 1998, Pages 353-359

  Hasan, Qurratulain ^a   Dunbar, P Rod ^a   Murray McIntosh, Rosalind P ^b   Neale, T James ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

Alternative transcripts; Competitive RT PCR; Glomerulonephropathies; Renal disease; TGF isoforms

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CELL PROLIFERATION; GLOMERULONEPHRITIS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FIBROSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032454954     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1998.tb00371.x     Document Type: Article

References (34)

1. 1. Sporn MB, Roberts AB, Wakefield LM, Assolan RK. Transforming growth factor-α: biological function and chemical structure. Science 1986; 233: 532-4.
2. 2. Sharma K, Ziyadeh FN. The transforming growth factor-β system and the kidney. Semin. Nephrol. 1993; 13: 116-28.
3. 3. Sharma K, Ziyadeh FN. The emerging role of transforming growth factor-β in kidney diseases. Am. J. Physiol 1994; 266: F829-42.
4. 4. Massague J. The transforming growth factor-β system. Annu. Rev. Cell Biol. 1990; 6: 597-641.
5. 5. Shull MM, Ormsley I, Kier AB et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature Lond. 1992; 359: 693-9.
6. 6. Yaswen L, Kulkarni AB, Fredrickson T et al. Autoimmune manifestations in the transforming growth factor-β1 knockout mouse. Blood 1996; 87: 1439-45.
7. 7. Dickson MC, Slager HG, Duffie E et al. RNA and protein localisations of TGF-β2 in the early mouse embryo suggest an involvement in cardiac development. Development 1993; 117: 625-39.
8. 8. Schmid P, Cox D, Bilbe G. Differential expression of TGF-β1, β2 and β3 genes during mouse embryogenesis. Development 1991; 111: 117-30.
9. 9. Bruijn JA, Roos A, de Geus B, de Heer E. Transforming growth factor-β and the glomerular extracellular matrix in renal pathology. J. Lab. Clin. Med. 1994; 123: 34-47.
10. 10. Thompson NL, Flanders KC, Smith JM et al. Expression of TGF-β1 in specific cells and tissues of adult and neonatal mice. J. Cell Biol. 1989; 108: 661-9.
11. 11. Bascom CC, Wolfshohl JR, Coffey RJ. Complex regulation of TGF-β1, β2 mRNA expression in mouse fibroblasts and keratinocytes by TGF-β1 and β2. Mol. Cell. Biol. 1989; 9: 5508-15.
12. 12. Wardle N. Glomerulosclerosis: the final pathway is clarified, but can we deal with the triggers? Nephron 1996; 73: 1-7.
13. 13. Border WA, Ruoslahti E. TGF-β in disease: the dark side of tissue repair. J. Clin. Invest. 1992; 90: 1-7.
14. 14. Border WA, Okuda S, Nakamura T. Extracellular matrix and glomerular disease. Semin. Nephrol. 1989; 9: 307-17.
15. 15. Border WA, Noble NA. TGF-β in kidney fibrosis: a target for gene therapy. Kidney Int. 1997; 51: 1388-96.
16. 16. Nakamura T, Miller D, Ruoslahti E, Border WA. Production of extracellular matrix by glomerular epithelial cells is regulated by TGF-β1. Kidney Int. 1992; 41: 1213-21.
17. 17. Shankland SJ, Scholey JW. Expression of TGF-β1 during diabetic renal hypertrophy. Kidney Int. 1994; 46: 430-42.
18. 18. Shihab FS, Andoh TF, Tanner AM et al. Role of TGFβ1 in experimental chronic cyclosporine nephropathy. Kidney Int. 1996; 49: 1141-51.
19. 19. Yamamoto T, Nakamura T, Noble NA et al. Expression of TGFβ is elevated in human and experimental diabetic glomerulopathy. Proc. Natl Acad. Sci. USA 1993; 90: 1814-18.
20. 20. Yoshioka K, Takemura T, Murakami K et al. TGF-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab. Invest. 1993; 68: 154-63.
21. 21. Iwano M, Akai Y, Fujii Y et al. Intraglomerular expression of TGF-β1 mRNA in patients with glomerulonephritis: quantitative-analysis by competitive polymerase chain reaction. Clin. Exp. Immunol. 1994; 97: 309-14.
22. 22. Iwano M, Kubo A, Nishino T et al. Quantification of glomerular TGFβ1 in RNA in patients with diabetes mellitus. Kidney Int. 1996; 49: 1120-6.
23. 23. Niemir ZI, Stein H, Noronha IL et al. PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis. Kidney Int. 1995; 48: 1530-41.
24. 24. Pankewycz OG, Guan J-X, Bolton WK et al. Renal TGF-β regulation in spontaneously diabetic NOD mice with correlations in mesangial cells. Kidney Int. 1994; 46: 748-58.
25. 25. Yamamoto T, Noble NA, Cohen AH et al. Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int. 1996; 49: 461-9.
26. 26. Shankland SJ, Pippin J, Pichier RH et al. Differential expression of transforming growth factor-β isoforms and receptors in experimental membranous nephropathy. Kidney Int. 1996; 50: 116-24.
27. 27. Gilliland G, Perrin S, Blanchard K, Bunn HF. Analysis of cytokine mRNA and DNA. Detection and quantitation by competitive polymerase chain reaction. Proc. Natl Acad. Sci. USA 1990; 87: 2725-9.
28. 28. Ruger BM, Hasan Q, Greenhill NS, Davis PF, Dunbar PR, Neale TJ. Mast cells and type VIII collagen in human diabetic nephropathy. Diabetologia 1996; 39: 1215-22.
29. 29. Hasan Q, Dunbar PR, Ruger BM et al. Analysis of the expression of multiple cytokines in individual human renal biopsies. Kidney Int. 1997; 51: 1311-12.
30. 30. Uberla K, Platzer C, Diamantstein T, Blankenstein T. Generation of competitive DNA fragments for quantitative PCR. PCR Method. Applications 1991; 1: 136-9.
31. 31. Bottinger EP, Letterio JJ, Roberts AB. Biology of TGFβ in knockout and transgenic mouse models. Kidney Int. 1997; 51: 1355-60.
32. 32. Horvath LZ, Friess H, Schilling M et al. Altered expression of transforming growth factor-β in chronic renal rejection. Kidney Int. 1996; 50: 489-98.
33. 33. Madisen L, Webb NR, Rose TM et al. TGF-β2: cDNA cloning and sequence analysis. DNA 1988; 7: 1-8.
34. 34. de Martin R, Haendler B, Hofer-Warbinek R et al. cDNA for human glioblastoma-derived T-cell suppressor factor, a novel member of the TGF-β gene family. EMBO J. 1987; 6: 3673-7.